Skip to content

ARGOS THERAPEUTICS INC: 10-K filed 2016-03-30

What ARGOS THERAPEUTICS INC reported in its annual report filed 2016-03-30 (fiscal FY 2015): 32 published measures, 128 facts as tagged in accession 0001171843-16-008919.

This filing

Form
10-K (annual report)
Filed
2016-03-30
Fiscal period
fiscal FY 2015
Accession
0001171843-16-008919 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARGOS THERAPEUTICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-12-3131,131,202USD
At 2014-12-3164,366,878USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-12-31-28,201,435USD
At 2014-12-3131,351,804USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-12-316,163,144USD
At 2014-12-3137,223,590USD
At 2013-12-3133,297,970USD
At 2012-12-318,214,865USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-74,788,521USD365
2014-10-01 to 2014-12-31-16,220,410USD92
2014-01-01 to 2014-12-31-53,305,938USD365
2014-07-01 to 2014-09-30-15,101,017USD92
2014-04-01 to 2014-06-30-11,983,531USD91
2014-01-01 to 2014-03-31-10,000,980USD90
2013-01-01 to 2013-12-31-23,921,563USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-12-319,686,643USD365
2014-01-01 to 2014-12-311,097,798USD365
2013-01-01 to 2013-12-31596,455USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-10-01 to 2015-12-3173,818USD92
2015-01-01 to 2015-12-31518,329USD365
2015-07-01 to 2015-09-30158,349USD92
2015-04-01 to 2015-06-30107,391USD91
2015-01-01 to 2015-03-31178,771USD90
2014-10-01 to 2014-12-31303,453USD92
2014-01-01 to 2014-12-311,974,019USD365
2014-07-01 to 2014-09-30398,615USD92
2014-04-01 to 2014-06-30473,163USD91
2014-01-01 to 2014-03-31798,788USD90
2013-01-01 to 2013-12-314,421,689USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-12-31-278,958,707USD
At 2014-12-31-204,170,186USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
1997-05-08 to 2015-12-310USD6812

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-12-3122,306,384USD
At 2014-12-315,513,555USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-12-314,014,938USD365
2014-01-01 to 2014-12-313,013,283USD365
2013-01-01 to 2013-12-311,081,186USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-16,942,838USD92
2015-01-01 to 2015-12-31-72,547,505USD365
2015-07-01 to 2015-09-30-19,758,454USD92
2015-04-01 to 2015-06-30-18,886,801USD91
2015-01-01 to 2015-03-31-16,959,412USD90
2014-10-01 to 2014-12-31-15,635,750USD92
2014-01-01 to 2014-12-31-52,124,256USD365
2014-07-01 to 2014-09-30-14,919,830USD92
2014-04-01 to 2014-06-30-11,961,793USD91
2014-01-01 to 2014-03-31-9,606,883USD90
2013-01-01 to 2013-12-31-24,231,779USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-12-318,813,798USD
At 2014-12-3157,517,303USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-01-01 to 2015-12-312,263,599USD365
2014-01-01 to 2014-12-311,123,579USD365
2013-01-01 to 2013-12-314,705USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-12-318,162,813USD
At 2014-12-313,296,754USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-12-312,907,683USD
At 2014-12-311,860,491USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-01-01 to 2015-12-3173,065,834USD365
2014-01-01 to 2014-12-3154,098,275USD365
2013-01-01 to 2013-12-3128,653,468USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-10-01 to 2015-12-3113,975,602USD92
2015-01-01 to 2015-12-3162,054,823USD365
2015-07-01 to 2015-09-3017,227,405USD92
2015-04-01 to 2015-06-3016,084,834USD91
2015-01-01 to 2015-03-3114,766,982USD90
2014-10-01 to 2014-12-3113,459,178USD92
2014-01-01 to 2014-12-3145,498,916USD365
2014-07-01 to 2014-09-3012,998,409USD92
2014-04-01 to 2014-06-3010,569,134USD91
2014-01-01 to 2014-03-318,472,195USD90
2013-01-01 to 2013-12-3123,991,151USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-12-3121,641,509shares
At 2014-12-3119,657,412shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-12-31250,873,875USD
At 2014-12-31235,627,174USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2015-12-31-138,245USD
At 2014-12-31-124,841USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2015-12-3132,400,000USD
At 2014-12-3119,800,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-12-3131,150,719USD
At 2014-12-3113,749,884USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-12-318,844,335USD
At 2014-12-318,236,329USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-12-3111,020USD
At 2014-12-3111,020USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-12-313,676,846USD
At 2014-12-311,405,378USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-12-31740,173USD
At 2014-12-31838,420USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-17,558,920USD92
2015-01-01 to 2015-12-31-74,788,521USD365
2015-07-01 to 2015-09-30-20,078,568USD92
2015-04-01 to 2015-06-30-19,604,818USD91
2015-01-01 to 2015-03-31-17,546,215USD90
2014-10-01 to 2014-12-3116,220,410USD92
2014-01-01 to 2014-12-31-54,169,164USD365
2014-07-01 to 2014-09-3015,101,017USD92
2014-04-01 to 2014-06-3011,983,531USD91
2014-01-01 to 2014-03-3110,864,206USD90
2013-01-01 to 2013-12-31-33,874,660USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-313,041,054USD92
2015-01-01 to 2015-12-3111,011,011USD365
2015-07-01 to 2015-09-302,689,398USD92
2015-04-01 to 2015-06-302,909,358USD91
2015-01-01 to 2015-03-312,371,201USD90
2014-10-01 to 2014-12-312,480,025USD92
2014-01-01 to 2014-12-318,599,359USD365
2014-07-01 to 2014-09-302,320,036USD92
2014-04-01 to 2014-06-301,865,822USD91
2014-01-01 to 2014-03-311,933,476USD90
2013-01-01 to 2013-12-314,662,317USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-12-31680,444USD365
2014-01-01 to 2014-12-31566,117USD365
2013-01-01 to 2013-12-31611,421USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-616,082USD92
2015-07-01 to 2015-09-30-320,114USD92
2015-04-01 to 2015-06-30-718,017USD91
2015-01-01 to 2015-03-31-586,803USD90
2014-10-01 to 2014-12-31-584,660USD92
2014-07-01 to 2014-09-30-181,187USD92
2014-04-01 to 2014-06-30-21,738USD91
2014-01-01 to 2014-03-31-394,097USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-2,241,016USD365
2014-01-01 to 2014-12-31-1,181,682USD365
2013-01-01 to 2013-12-31310,216USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-136,981USD365
2014-01-01 to 2014-12-31543,419USD365
2013-01-01 to 2013-12-31181,965USD365

Inspect the source

Entity
ARGOS THERAPEUTICS INC / CIK 0001105533
Captured
SEC response SHA-256
07ee84a7b42518f1df0d6d45cc8782b7755c6cd7cd844b2cc13a94f0396ce00f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001105533.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))